Skip to main content
Log in

Aerosol Electrostatics I: Properties of Fine Powders Before and After Aerosolization by Dry Powder Inhalers

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To evaluate the dependence of fine particle dose charge (FPD charge) generated from powder inhalers on physico-chemical properties of the inhalation powder, inhaler type, deaggregation mechanism, dose number and/or retained powder.

Methods. Electrostatic charges were determined on micronized powders and aerosolized fine particle doses withdrawn from two, high efficiency, multidose powder inhalers, Turbohalerand prototype Dryhaler. The behavior of terbutaline sulfate, budesonide, albuterol (sulfate and base), beclomethasone dipropionate and lactose was assessed before and after aerosolization.

Results. Both inhalers conferred triboelectric FPD charges during aerosolization in the range −400 pC through +200 pC. Specific charges (charge/unit mass) on the fine particle doses of budesonide from Dryhaler were significantly less than those from Turbohaler (p < 0.01). Electrostatic charges on the potentially respirable cloud of terbutaline sulfate generated by Bricanyl Turbohaler were positive and/or negative and unpredictable. With Pulmicort Turbohaler, FPD charges on budesonide were always positive. Dryhaler was used to determine the chemical dependence of fine particle triboelectrification during the aerosolization of pure materials. A triboelectric series was constructed from the Dryhaler results ranking the powders from positive to negative as budesonide > lactose > albuterol sulfate > terbutaline sulfate ≥ albuterol ≥ beclomethasone dipropionate.

Conclusions. While there was no evidence of FPD charge dependence upon dose number with either inhaler, FPD charges were dependent upon the powder under investigation, as well as the construction and deaggregation mechanism of the inhaler. The specific charge on the fine particle dose of budesonide from Turbohaler corresponded to approximately 200 electronic charges per particle, a value which is known to affect both total and regional aerosol deposition in the human lung. Electrostatic charge effects may be important determinants of aerosol behavior and should not be neglected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Task Group on Lung Dynamics. Health Physics, 12:173–207 (1966).

    Google Scholar 

  2. P. R. Byron and A. R. Clark. Journal of Pharmaceutical Sciences, 74:934–938 (1985).

    PubMed  Google Scholar 

  3. C. Melandri, V. Prodi, G. Tarroni, M. Formignani, T. De Zaiacomo, G. F. Bompane, and G. Maestri. In: W.H. Walton (Ed.). Inhaled Particles IV. Pergammon Press: Oxford, 1977, pp 193–201.

    Google Scholar 

  4. C. Melandri, G. Tarroni, V. Prodi, T. De Zaiacomo, M. Formignani, and C. C. Lombardi. Journal of Aerosol Science, 14:657–669 (1983).

    Google Scholar 

  5. W. Balachandran, C. N. Ahmad, and S. A. Barton. Institute of Physics Conference Series, 118:57–62 (1991).

    Google Scholar 

  6. A. H. Hashish, A. G. Bailey, and T. J. Williams. Physics in Medicine and Biology, 39:2247–2262 (1994).

    Google Scholar 

  7. C. O'Callaghan, J. Lynch, M. Cant, and C. Robertson. Thorax, 48:603–606 (1993).

    PubMed  Google Scholar 

  8. P. W. Barry, and C. O'Callaghan. Thorax, 49:402. (1994).

    Google Scholar 

  9. P. W. Barry, and C. O'Callaghan. British Journal of Clinical Pharmacology, 40:76–78 (1995).

    PubMed  Google Scholar 

  10. N. J. Dewsbury, C. J. Kenyon, and S. P. Newman. International Journal of Pharmaceutics, 137:261–264 (1996).

    Google Scholar 

  11. W. C. Hinds. Aerosol Technology: Properties, Behaviour and measurement of airbourne particles. Wiley Interscience, New York (1982).

    Google Scholar 

  12. J. N. Staniforth, and J. E. Rees. Journal of Pharmacy and Pharmacology, 34:69–76 (1982).

    PubMed  Google Scholar 

  13. K. Wetterlin. Pharmaceutical Research, 5:506–508 (1988).

    PubMed  Google Scholar 

  14. M. Hill. Respiratory Drug Delivery IV, P. R. Byron, R. N. Dalby, and S. J. Farr (Eds.), Interpharm Press: Deerfield, IL, pp 109–116 (1994).

    Google Scholar 

  15. V. A. Marple, B. A. Olson, and N. C. Miller. Aerosol Science and Technology, 22:124–134 (1995).

    Google Scholar 

  16. M. Hindle, P. R. Byron, and N. C. Miller. International Journal of Pharmaceutics, 134:137–146 (1996).

    Google Scholar 

  17. M. Hindle, and P. R. Byron. International Journal of Pharmaceutics, 116:169–177 (1995).

    Google Scholar 

  18. Astra Draco, Personal communication.

  19. Inhalanda Working Party. Pharmacopeial Forum, 22:3050–3064 (1996).

    Google Scholar 

  20. J. Peart, J. N. Staniforth, and B. J. Meakin. Institute of Physics Conference Series, 143:271–274 (1995).

    Google Scholar 

  21. A. D. Zimon. Adhesion of dust and powder. Consultant Bureau: New York (1982).

    Google Scholar 

  22. E. Berg. Respiratory Drug Delivery V, R. N. Dalby, P. R. Byron, and S. J. Farr (Eds.). Interpharm Press: Deerfield, IL, pp 308–311 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Byron, P.R., Peart, J. & Staniforth, J.N. Aerosol Electrostatics I: Properties of Fine Powders Before and After Aerosolization by Dry Powder Inhalers. Pharm Res 14, 698–705 (1997). https://doi.org/10.1023/A:1012181818244

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012181818244

Navigation